Saturday, July 11, 2026

pharma · Advanced Gastric or Gastroesophageal Junction Cancer · Dwarfism

GeneScience Pharmaceuticals Co

GeneScience Pharmaceuticals Co trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
30 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
30
Programs
3
Drugs
4
Patents
0
Intelligence · Clinical Trials

GeneScience Pharmaceuticals Co clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to GeneScience Pharmaceuticals Co programs — each row shows trial ID, program name, phase, status, and indication.

GeneScience Pharmaceuticals Co trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for GeneScience Pharmaceuticals Co.

  1. PEG-somatropin — Approved

    Clinical update
  2. PEG-somatropin — Phase 2

    Clinical update
  3. Gentuximab — Phase 2

    Clinical update

Trial registry

3 studies